sr 33557 has been researched along with fluspirilene in 1 studies
| Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (fluspirilene) | Trials (fluspirilene) | Recent Studies (post-2010) (fluspirilene) |
|---|---|---|---|---|---|
| 50 | 3 | 1 | 155 | 17 | 33 |
| Protein | Taxonomy | sr 33557 (IC50) | fluspirilene (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 10 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Kenny, B; Spedding, M | 1 |
1 review(s) available for sr 33557 and fluspirilene
| Article | Year |
|---|---|
New drug binding sites in Ca2+ channels.
Topics: Animals; Binding Sites; Calcium Channel Blockers; Fluspirilene; Humans; Indolizines; Phenethylamines | 1995 |